Results of Dasatinib Therapy in Patients With Early Chronic-Phase Chronic Myeloid Leukemia

PURPOSE: Dasatinib is effective therapy for chronic myeloid leukemia (CML) after imatinib failure. In this study, we investigate the efficacy of dasatinib as initial therapy for patients with CML in early chronic phase. PATIENTS AND METHODS: Patients with newly diagnosed CML in early chronic phase w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Cortes, Jorge E., Jones, Dan, O'Brien, Susan, Jabbour, Elias, Ravandi, Farhad, Koller, Charles, Borthakur, Gautam, Walker, Brenda, Zhao, Weiqiang, Shan, Jianqin, Kantarjian, Hagop
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2010
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2815702/
https://ncbi.nlm.nih.gov/pubmed/20008620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.25.4920
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados